“Immunotherapy for Recurrent Orthostatic Cerebral Hypo-Perfusion Syndrome in Recurrent COVID-19 Infection”. 2021. Nepal Journal of Neuroscience 18 (2): 64-66. https://doi.org/10.3126/njn.v18i2.35516.